b

bioMérieux
BIM

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€14.22B
EV
€14.27B
Shares Outstanding
117.93M
Beta
0.48

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€123.54
P/E 2025E
26.57x
P/Revenue 2025E
3.33x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About bioMérieux S.A.

gainify

b

bioMérieux S.A.

BIM

bioMérieux S.A. develops and markets in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemica...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Boulud, Pierre

Employees

14,451

IPO Date

2004-07-07

Headquarters

376 Chemin De l’Orme, Marcy-l'Étoile, Rhône-Alpes, 69280, France

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.